Guangxi Lingfeng Pharmaceutical Company Limited Sustainability Profile
Guangxi Lingfeng Pharmaceutical Company Limited, often referred to as Lingfeng Pharma, is a prominent player in the pharmaceutical industry, headquartered in the Guangxi Zhuang Autonomous Region of China. Established in 2001, the company has made significant strides in the development and production of high-quality pharmaceutical products, particularly in the fields of traditional Chinese medicine and modern pharmaceuticals. Lingfeng Pharma is renowned for its innovative approach to healthcare, offering a diverse range of core products, including herbal medicines and prescription drugs. The company’s commitment to quality and efficacy has positioned it as a trusted name in the market, with a strong presence in both domestic and international regions. Notable achievements include various industry certifications and a growing portfolio that reflects its dedication to advancing health solutions.
DitchCarbon Score
How does Guangxi Lingfeng Pharmaceutical Company Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Guangxi Lingfeng Pharmaceutical Company Limited's score of 22 is lower than 79% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Guangxi Lingfeng Pharmaceutical Company Limited's reported carbon emissions
Guangxi Lingfeng Pharmaceutical Company Limited, headquartered in China (CN), currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of American Oriental Bioengineering, Inc., which may influence its climate-related initiatives and reporting practices. Despite the lack of direct emissions data, Guangxi Lingfeng Pharmaceutical has not outlined any specific reduction targets or climate pledges. This suggests that the company may still be in the early stages of developing a comprehensive climate strategy or may rely on the broader commitments of its parent company. As a subsidiary, Guangxi Lingfeng Pharmaceutical's climate commitments may be informed by the sustainability practices and targets set by American Oriental Bioengineering, Inc. However, without explicit data or commitments from Guangxi Lingfeng itself, it is challenging to assess its carbon footprint or climate action plans accurately. In summary, while Guangxi Lingfeng Pharmaceutical Company Limited is part of a corporate family that may have climate initiatives, it currently lacks specific emissions data and defined reduction targets.
How Carbon Intensive is Guangxi Lingfeng Pharmaceutical Company Limited's Industry?
How Carbon Intensive is Guangxi Lingfeng Pharmaceutical Company Limited's Location?
Guangxi Lingfeng Pharmaceutical Company Limited's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Guangxi Lingfeng Pharmaceutical Company Limited has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
